Biosensors & POCT– category –
-
GoodRx Compares Leading CGMs: Dexcom G7 10-Day Sensor Emerges as Sole FDA-Approved Device for Children Ages 2+
GoodRx USA Overview According to a GoodRx comparison report, the Dexcom G7 10-day sensor is FDA-approved for adults and children aged 2 and older, while the Dexcom G7 15-day sensor and Eversense 365 are approved exclusively for adults ag... -
AI, Digital Health, & Remote Monitoring Revolutionize Obesity Care: Real-time Intervention via Wearables & Mobile Apps
AI in Digital Health & Remote Monitoring India Overview Artificial Intelligence (AI), digital health platforms, and remote patient monitoring systems are rapidly transforming the healthcare industry's approach to obesity and metabolic di... -
CRP Point-of-Care Testing (POCT) Significantly Reduces Pediatric Antibiotic Prescriptions by 20-30%
Aidian フィンランド Overview New findings from two large-scale randomized controlled trials (COORDINATE and ARON) demonstrate that C-reactive protein (CRP) Point-of-Care Testing (POCT) can safely and effectively guide antibiotic use in c... -
UNSW Unveils ‘AusculPatch’ AI-Integrated Ultralight Wearable Sensor for Continuous Home Heart & Lung Monitoring
ICT&health Australia Overview Researchers at the University of New South Wales (UNSW) have developed 'AusculPatch,' an ultralight wearable sensor designed for continuous home monitoring of patients with heart and lung conditions. The sen... -
Osaka University Develops Fluorescence Biosensor Tracking Rare Lipid PI(3,5)P2 Accumulation During Cell Stress via CLiB Assay
Feed and Figures (Source: Phys.org) Japan Overview Researchers at Osaka University have developed a groundbreaking biosensor to track the accumulation of the rare lipid PI(3,5)P2 within cell membranes during cellular stress. The newly in... -
The Rise of Finger-Prick-Free Glucose Monitoring: Dexcom Stelo, Abbott Lingo, and the CGM Revolution in Metabolic Health
Mattioli 1885 イタリア Overview The U.S. FDA has approved a new generation of finger-prick-free continuous glucose monitors (CGMs) that measure interstitial fluid glucose and transmit real-time data to smartphones, largely eliminating da... -
China’s POCT Industry Enters ‘Golden Globalization Era’ Driven by EU IVDR Reforms and Global Outbreaks
Hangzhou AllTest Biotech CO.,LTD China Overview China's Point-of-Care Testing (POCT) industry is entering a 'golden era' of globalization, fueled by stricter EU IVDR regulations and frequent global infectious disease outbreaks. The EU IV... -
Trinity Biotech’s AI-Powered CGM+ Biosensor Slashes False Low Glucose Alarms by Over 95%
Trinity Biotech plc (NASDAQ: TRIB) アイルランド Overview Trinity Biotech plc has announced groundbreaking clinical trial results for its next-generation CGM+ wearable biosensor platform. This innovative system leverages AI-driven analyti... -
Convergence Reports on Next-Gen Wearable Biosensors Using Aptamers for Real-time Molecular Health Monitoring
Convergence Netherlands Overview Dr. Alina Rwei's research team is developing next-generation wearable biosensors that measure biomarkers from minute bodily fluids like sweat and interstitial fluid. These miniature devices aim to track b... -
FDA Clears Dexcom Stelo as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children (Ages 2+)
HCPLive USA Overview The FDA has approved Dexcom's Stelo Glucose Biosensor System for over-the-counter (OTC) use in children aged 2 years and older who do not use insulin. This marks Stelo as the first OTC continuous glucose monitoring (...
